The unit dosage production market sales in 2022 were steady at roughly US$ 22 billion. According to the report, the market is expected to increase at a notable rate of 22.4% between 2022 and 2032, with a final valuation of US$ 164 billion. Over the estimated period from 2022 to 2032, outsourcing is expected to generate the most revenue, with a compound annual growth rate (CAGR) of 19.8% and 22.8%, respectively. The biggest revenue-generating filament is expected to be solid unit dose.
The advantages of unit dose production, such as comprehensive drug identification and maintenance of the dosage form’s integrity till the moment of administration, are anticipated to propel market growth. Unit dosage repackaging has become more common as a result of FDA regulations governing unit dose-packed oral solid medicines. Unit dosages must be
Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14770
Unit doses have also raised patient and staff safety standards by eliminating the possibility of erroneous dosing. They use electronic papers to facilitate speedy and effective monitoring, and it is easy to spot any broken containers when using liquid unit doses. Unit doses can also save consumers money on medications they do not need. The projected double-digit growth during the period of projection is expected to further increase the market size.
Key Takeaways from the Market Study
- Global Unit Dose Manufacturing market is estimated to reach a market size of around US$ 22 Billion by 2022
- Top Type being Outsourcing expected to grow at a CAGR of 19.8%.
- Top Filament being Solid Unit Dose expected to grow at a CAGR of 22.8%.
- With over 25% projected growth rate, Unit Dose Manufacturing revenue is expected to grow at fastest pace in Asia Pacific, during 2022 to 2032.
Benefits associated with manufacturing unit doses over packaging, and flourishing pharmaceutical industry, are expected to shape the overall Unit Dose Manufacturing market, comments a Sabyasachi Ghosh analyst.
Competitive Landscape
A large number of regional and global players operate in the unit dose manufacturing market. A variety of strategies are being employed by companies to remain competitive. According to the market research analysis, partnerships and expansion have been the prominent development in Unit Dose Manufacturing market in recent year. Catalent Inc, Patheon, Unither, Mikart, Tapemark, Renaissance, Medical packaging Inc, Corden pharma, and American health packaging are the prominent providers of Unit Dose Manufacturing services.
- In August 2020, Nanjing Ruinian Best Pharmaceutical Co. Ltd. was acquired by Unither Pharmaceuticals August 2020. This acquisition was reported to be focused on aiding Unither Pharmaceuticals expand in China through offering experience regarding medication research and single-dose sterile drugs without preservatives.
Future Market Insights’ Domain Knowledge in Healthcare Division
Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare domain team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analysed the Healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.
Key Companies Profiled:
- Catalent Inc.
- Patheon (Thermo fisher)
- Unither
- Tapemark
- Mikart
- Renaissance Lakewood, LLC
- Medical packaging, Inc.
- CordenPharma
- American Health Packaging
Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14770
Market Segments Covered in Unit Dose Manufacturing Industry Analysis
By Type:
- In-House
- Outsourcing
By Filament:
- Solid Unit Dose
- Liquid Unit Dose
- Other Filaments
By Application:
- Independent Pharmacies
- Long Term Care Facility
- Hospitals
- Others
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube